Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BJDX Bluejay Diagnostics Inc

Closed 12-22 16:00:00 EST

0.7680

-0.0320

-4.00%

盘后0.7620

-0.0060-0.78%

19:58 EST

High0.8100	Low0.7116	Vol139.36K
Open0.8000	D1 Closing0.8000	Amplitude12.30%
Mkt Cap1.39M	Tradable Cap924.75K	Total Shares1.81M
T/O105.61K	T/O Rate11.57%	Tradable Shares1.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BJDX","market":"US","secType":"STK","nameCN":"Bluejay Diagnostics Inc","latestPrice":0.768,"timestamp":1766437200000,"preClose":0.8,"halted":0,"volume":139362,"hourTrading":{"tag":"盘后","latestPrice":0.762,"preClose":0.768,"latestTime":"19:58 EST","volume":1335,"amount":1023.893304,"timestamp":1766451503904},"delay":0,"floatShares":1204100,"shares":1814100,"eps":-6.77855,"marketStatus":"Closed","change":-0.032,"latestTime":"12-22 16:00:00 EST","open":0.8,"high":0.81,"low":0.7116,"amount":105612.0842991,"amplitude":0.123,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-6.77855,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766480400000},"marketStatusCode":5,"adr":0,"listingDate":1636520400000,"exchange":"NASDAQ","adjPreClose":0.8,"preHourTrading":{"tag":"盘前","latestPrice":0.852,"preClose":0.8,"latestTime":"09:13 EST","volume":760,"amount":634.5168560000001,"timestamp":1766412782717},"postHourTrading":{"tag":"盘后","latestPrice":0.762,"preClose":0.768,"latestTime":"19:58 EST","volume":1335,"amount":1023.893304,"timestamp":1766451503904},"volumeRatio":1.471324},"requestUrl":"/m/hq/s/BJDX","defaultTab":"news","newsList":[{"id":"2582385808","title":"Bluejay Diagnostics Reports Q3 Results and Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2582385808","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582385808?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:48","pubTimestamp":1762811318,"startTime":"0","endTime":"0","summary":"An update from Bluejay Diagnostics ( ($BJDX) ) is now available. On November 10, 2025, Bluejay Diagnostics announced its third-quarter financial re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-reports-q3-results-and-updates?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-reports-q3-results-and-updates?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2582287915","title":"Bluejay Diagnostics provides Q3 corporate update","url":"https://stock-news.laohu8.com/highlight/detail?id=2582287915","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582287915?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:55","pubTimestamp":1762779358,"startTime":"0","endTime":"0","summary":"Third Quarter 2025 and Recent Corporate Highlights: SYMON-II Pivotal Clinical Study Continues: Bluejay continues patient enrollment in the SYMON-II...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-provides-q3-corporate-update-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-provides-q3-corporate-update-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2582879316","title":"Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879316","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879316?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:30","pubTimestamp":1762777800,"startTime":"0","endTime":"0","summary":"Company focused on advancing clinical milestones and strategic partnerships, with goal of positioning itself for future FDA clearance and product commercialization.Patient enrollment in SYMON-II clini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/10/3184423/0/en/Bluejay-Diagnostics-Corporate-Update-Advancing-Clinical-Milestones-and-Strategic-Partnerships.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2578062935","title":"Bluejay Diagnostics Advances Sepsis Study with IL-6 Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2578062935","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578062935?lang=en_us&edition=fundamental","pubTime":"2025-10-28 00:53","pubTimestamp":1761584009,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics, Inc. (($BJDX)) announced an update on their ongoing clinical study. Bluejay Diagnostics, Inc. is conducting a study titled ‘Mu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-advances-sepsis-study-with-il-6-monitoring?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-advances-sepsis-study-with-il-6-monitoring?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX"],"gpt_icon":0},{"id":"2577753440","title":"Bluejay Diagnostics files to sell 6.93M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2577753440","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577753440?lang=en_us&edition=fundamental","pubTime":"2025-10-24 05:05","pubTimestamp":1761253524,"startTime":"0","endTime":"0","summary":"The company is not selling any shares of common stock under this prospectus and will not receive any proceeds from the sale of shares of common sto...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-files-to-sell-6-93m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-files-to-sell-6-93m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2575724291","title":"BRIEF-Bluejay Diagnostics Inc - Enters Into Securities Purchase Agreement On Oct 9 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575724291","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575724291?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:07","pubTimestamp":1760440040,"startTime":"0","endTime":"0","summary":"BRIEF-Bluejay Diagnostics Inc - Enters Into Securities Purchase Agreement On Oct 9 - SEC FilingOct 14  - Bluejay Diagnostics Inc BJDX.O:BLUEJAY DIAGNOSTICS INC - ENTERS INTO SECURITIES PURCHASE AGREEMENT ON OCT 9 - SEC FILINGBLUEJAY DIAGNOSTICS INC - PRIVATE PLACEMENT CLOSED ON OCTOBER 10, 2025 - SEC FILINGSource text: [ID:n0001213900-25-098281]Further company coverage: BJDX.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VU2ZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2575629196","title":"Bluejay Diagnostics Raises $4M in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2575629196","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575629196?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:55","pubTimestamp":1760439317,"startTime":"0","endTime":"0","summary":"The latest update is out from Bluejay Diagnostics ( ($BJDX) ). On October 9, 2025, Bluejay Diagnostics, Inc. announced a private placement of its s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-raises-4m-in-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-raises-4m-in-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2575969142","title":"Bluejay Diagnostics Inc - Private Placement Closed on October 10, 2025 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575969142","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575969142?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:20","pubTimestamp":1760437229,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VU2ZK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2575296874","title":"Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2575296874","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575296874?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:17","pubTimestamp":1760437058,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics Inc. has announced a $4.5 million private placement priced at-the-market under Nasdaq rules. The company has entered into definitive agreements for the sale of 2,250,000 shares of common stock  and Series F warrants to purchase up to 4,500,000 shares of common stock, at a purchase price of $2.00 per share and accompanying warrant. The Series F warrants have an exercise price of $1.75 per share, are exercisable immediately, and will expire 5.5 years from issuance. Rodman and Renshaw LLC is acting as the exclusive placement agent for the offering. Bluejay Diagnostics intends to use the net proceeds to support FDA approval efforts, research and development activities, and general working capital.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDLbX90Zk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2574488561","title":"Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2574488561","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574488561?lang=en_us&edition=fundamental","pubTime":"2025-10-11 05:16","pubTimestamp":1760130960,"startTime":"0","endTime":"0","summary":"ACTON, Mass., Oct.  10, 2025  (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/10/3165124/0/en/Bluejay-Diagnostics-Announces-Closing-of-4-5-Million-Private-Placement-Priced-At-The-Market-Under-Nasdaq-Rules.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX",".IXIC","TSYW.SI","MNQmain","BK4082","SQQQ","PSQ","QID","QLD","TQQQ","USJW.SI","NVIW.SI","USAW.SI","NQmain"],"gpt_icon":1},{"id":"2574195716","title":"Press Release: Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2574195716","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574195716?lang=en_us&edition=fundamental","pubTime":"2025-10-10 03:15","pubTimestamp":1760037300,"startTime":"0","endTime":"0","summary":"ACTON, Mass., Oct. 09, 2025  -- Bluejay Diagnostics, Inc.  , a medical diagnostics company developing near-patient solutions for critical care, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 2,250,000 shares of common stock  and Series F warrants to purchase up to 4,500,000 shares of common stock at a purchase price of $2.00 per share of common stock  and accompanying warrants in a private placement priced at-the-market under Nasdaq rules. The Series F warrants will have an exercise price of $1.75 per share and will be exercisable immediately upon issuance. The Series F warrants will expire 5.5 years from the date of issuance. The private placement is expected to close on or about October 10, 2025, subject to the satisfaction of customary closing conditions.Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NQmain","BK4082","MNQmain",".IXIC","BJDX","PSQ","NVIW.SI","TQQQ","USJW.SI","QLD","TSYW.SI","SQQQ","USAW.SI","QID"],"gpt_icon":1},{"id":"2574682471","title":"Bluejay Diagnostics Shares Jump 116% After Co Expands Partnership With Japan's Sanyoseiko for Sepsis Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2574682471","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574682471?lang=en_us&edition=fundamental","pubTime":"2025-10-09 21:37","pubTimestamp":1760017030,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nFWN3VQ1CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2574151999","title":"BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Oracle, Delta Air Lines","url":"https://stock-news.laohu8.com/highlight/detail?id=2574151999","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574151999?lang=en_us&edition=fundamental","pubTime":"2025-10-09 19:39","pubTimestamp":1760009978,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Oracle, Delta Air LinesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nL6N3VQ0K7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B775SV38.USD","LU1878469433.USD","LU1935042991.SGD","FRPT","LU0719512351.SGD","JBLU","LU0128526141.USD","AKRO","BJDX","LU1035773651.USD","LU1267930227.SGD","NB","LU1974910355.USD","LU0444971666.USD","LU0965509010.AUD","DAL","LU0082616367.USD","UAL","LU1037948897.HKD","IE00BMPRXR70.SGD","LU2108987350.USD","BK4097","BK4168","AAL","BK4548","LU0029874061.USD","ORCL","LUV","LU1366192091.USD","BK4581","BK4139","LU1861214812.USD","LU0823414551.USD","LU2023250504.SGD","LU1815336760.USD","LU1861219969.SGD","SG9999003800.SGD","LU2054465674.USD","TREX","LU0070302665.USD","BK4534","LU2360106780.USD","LU2458330169.SGD","LU0068578508.USD","LU2506951792.HKD","ALB","LU1989764664.SGD"],"gpt_icon":1},{"id":"2574315307","title":"Bluejay Diagnostics Inc: Enters Into Agreement to Amend Master Service Agreement and Master Supply Agreement With Sanyoseiko Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2574315307","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574315307?lang=en_us&edition=fundamental","pubTime":"2025-10-09 18:30","pubTimestamp":1760005800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nTUAJKHNM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2574550921","title":"Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2574550921","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574550921?lang=en_us&edition=fundamental","pubTime":"2025-10-09 18:30","pubTimestamp":1760005800,"startTime":"0","endTime":"0","summary":"ACTON, Mass. and YAMANASHI, Japan, Oct.  09, 2025  (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), a medical diagnostics company focused on developing rapid near-patient test","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/09/3163975/0/en/Bluejay-Diagnostics-and-SanyoSeiko-Expand-Strategic-Partnership-to-Advance-Commercialization-of-Symphony-Platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2559499079","title":"Bluejay Diagnostics Inc - Donald R. Chase Appointed Chairperson of Bluejay Board - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2559499079","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559499079?lang=en_us&edition=fundamental","pubTime":"2025-08-16 05:30","pubTimestamp":1755293404,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nFWN3U70XO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2559949948","title":"Bluejay Diagnostics Announces New Leadership Appointments: Donald R. Chase Named Board Chairperson","url":"https://stock-news.laohu8.com/highlight/detail?id=2559949948","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559949948?lang=en_us&edition=fundamental","pubTime":"2025-08-16 05:28","pubTimestamp":1755293301,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics Inc. announced changes to its Board of Directors' leadership roles effective August 15, 2025. Donald R. Chase has been appointed as Chairperson of the Board, succeeding Douglas C. Wurth. Mr. Wurth will now serve as Chairperson of the Nominating and Corporate Governance Committee, taking over from Fred S. Zeidman. Mr. Zeidman has been named Chairperson of the Compensation Committee, succeeding Mr. Chase. Mr. Chase continues as Chairperson of the Audit Committee. These appointments follow the Board's regular review of governance assignments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluejay Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDLbTT2SN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2558564376","title":"Bluejay Diagnostics Announces Q2 2025 Results and Progress on SYMON-II Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2558564376","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558564376?lang=en_us&edition=fundamental","pubTime":"2025-08-11 18:03","pubTimestamp":1754906598,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluejay Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 11, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nNDL9nvbX2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Bluejay Diagnostics Announces Q2 2025 Results and Progress on SYMON-II Clinical Trial","news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2557932592","title":"Bluejay Diagnostics Q2 EPS $(1.41) Up From $(256.16) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2557932592","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557932592?lang=en_us&edition=fundamental","pubTime":"2025-08-08 06:32","pubTimestamp":1754605921,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.41) per share. This is a 99.45 percent increase over losses of $(256.16) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46985469/bluejay-diagnostics-q2-eps-1-41-up-from-256-16-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Bluejay Diagnostics Q2 EPS $(1.41) Up From $(256.16) YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX"],"gpt_icon":0},{"id":"2557924365","title":"Bluejay Diagnostics Provides Second Quarter Business and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2557924365","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557924365?lang=en_us&edition=fundamental","pubTime":"2025-08-08 06:30","pubTimestamp":1754605800,"startTime":"0","endTime":"0","summary":"ACTON, Mass., Aug.  07, 2025  (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/07/3129861/0/en/Bluejay-Diagnostics-Provides-Second-Quarter-Business-and-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://bluejaydx.com","stockEarnings":[{"period":"1week","weight":-0.2381},{"period":"1month","weight":-0.4366},{"period":"3month","weight":-0.4521},{"period":"6month","weight":-0.4872},{"period":"1year","weight":-0.7949},{"period":"ytd","weight":-0.8357}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.203804},{"month":2,"riseRate":0.5,"avgChangeRate":0.082808},{"month":3,"riseRate":0.5,"avgChangeRate":-0.104792},{"month":4,"riseRate":0.25,"avgChangeRate":-0.27562},{"month":5,"riseRate":0.25,"avgChangeRate":-0.095203},{"month":6,"riseRate":0.5,"avgChangeRate":-0.162527},{"month":7,"riseRate":0.5,"avgChangeRate":-0.039437},{"month":8,"riseRate":0,"avgChangeRate":-0.219139},{"month":9,"riseRate":0.25,"avgChangeRate":-0.176769},{"month":10,"riseRate":0.5,"avgChangeRate":-0.040237},{"month":11,"riseRate":0,"avgChangeRate":-0.194266},{"month":12,"riseRate":0.2,"avgChangeRate":-0.232963}],"exchange":"NASDAQ","name":"Bluejay Diagnostics Inc","nameEN":"Bluejay Diagnostics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Bluejay Diagnostics Inc,BJDX,Bluejay Diagnostics Inc股票,Bluejay Diagnostics Inc股票老虎,Bluejay Diagnostics Inc股票老虎国际,Bluejay Diagnostics Inc行情,Bluejay Diagnostics Inc股票行情,Bluejay Diagnostics Inc股价,Bluejay Diagnostics Inc股市,Bluejay Diagnostics Inc股票价格,Bluejay Diagnostics Inc股票交易,Bluejay Diagnostics Inc股票购买,Bluejay Diagnostics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}